ConductScience.org, home

Paper6406513

Chemotherapeutic study on Yoshida sarcoma ascites cells implanted into the glandular stomach of rats. Monotherapy with 5-fluorouracil, methyl-CCNU, mitomycin C, adriamycin, and cytosine arabinoside, and combination therapy with respective two-drug combinations.

Eichler G and 2 others. J Cancer Res Clin Oncol, 1983. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Chemotherapeutic study on Yoshida sarcoma ascites cells implanted into the glandular stomach of rats. Monotherapy with 5-fluorouracil, methyl-CCNU, mitomycin C, adriamycin, and cytosine arabinoside, and combination therapy with respective two-drug combinations. Papers, record 6406513. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6406513

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemotherapeutic study on Yoshida sarcoma ascites cells implanted into the glandular stomach of rats. Monotherapy with 5-fluorouracil, methyl-CCNU, mitomycin C, adriamycin, and cytosine arabinoside, and combination therapy with respective two-drug combinations.
PubMed
Journal
J Cancer Res Clin Oncol
PubMed
Year
1983
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.02
iCite
Revised in PubMed
2025-07-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Eichler GG
2Habs MM
3Schmähl DD

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Sarcoma, YoshidaMajor topic
Stomach NeoplasmsMajor topic
Animals
Antibiotics, Antineoplastic
Cytarabine
Disease Models, Animal
Doxorubicin
Drug Therapy, Combination
Fluorouracil
Male
Mitomycin
Mitomycins
Rats
Rats, Inbred Strains
Semustine

Source PubMed

Download CSV of topics

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
34552635-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer.Cancer1979https://conductscience.org/library/papers/455263PubMed
4402478Gastric cancer: current status of treatment.J Natl Cancer Inst1977https://conductscience.org/library/papers/402478PubMed
56414682Chemotherapy of disseminated gastric cancer. A joint effort of the Northern California Oncology Group and the Japanese Gastric Cancer Chemotherapy Group.Cancer1983https://conductscience.org/library/papers/6414682PubMed
613861733Five years clinical experience with 5-fluorouracil.JAMA1962https://conductscience.org/library/papers/13861733PubMed
74364381Editorial: Guidelines on the analysis of tumour rates and death rates in experimental animals.Br J Cancer1974https://conductscience.org/library/papers/4364381PubMed
84279136A review of chemotherapy in gastric cancer.Cancer1974https://conductscience.org/library/papers/4279136PubMed
97309781Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats.J Cancer Res Clin Oncol1981https://conductscience.org/library/papers/7309781PubMed
10788891Sequential and combination chemotherapy of advanced gastric cancer.Cancer1976https://conductscience.org/library/papers/788891PubMed
114174095[Quantitative studies in rats on the resistance of various organs to inoculated tumor cells].Z Krebsforsch1967https://conductscience.org/library/papers/4174095PubMed
127058280Chemotherapy of metastatic gastrointestinal cancers: prospects for future adjuvant systemic therapies.Recent Results Cancer Res1982https://conductscience.org/library/papers/7058280PubMed
1313300518[Quantitative transplantation experiments with the Yoshida ascites sarcoma in rats].Z Krebsforsch1955https://conductscience.org/library/papers/13300518PubMed
14782699Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.Cancer Treat Rep1976https://conductscience.org/library/papers/782699PubMed
15582732Studies on the effect of cyclophosphamide on Yoshida sarcoma ascites cells implanted into the colon wall of rats.Arzneimittelforschung1979https://conductscience.org/library/papers/582732PubMed
166935185Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments.IARC Monogr Eval Carcinog Risk Chem Hum Suppl1980https://conductscience.org/library/papers/6935185PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6406513

GET https://conductscience.org/api/papers/v1/6406513/authors